Rather than yet another study, the Cigna and ASAM research collaboration aims to leverage a trove of detailed claims data to identify the treatment variables that lead to optimal outcomes with lower costs.
Researcher Sergio Aguilar-Gaxiola has uncovered barriers to care, gaps in appropriate treatment services and other trends that speak to the opportunity for the behavioral health provider community to improve care delivery for the underserved.
Tom Frieden of the Centers for Disease Control and Prevention and Nora D. Volkow of the National Institute on Drug Abuse presented up-to-date information on opioid misuse in the context of today’s healthcare system.
Speaking to stakeholders today, President Obama underscored ongoing federal efforts to address the opioid and heroin crisis. In a panel discussion he also listened to the stories of people in recovery.
When the decision to prescribe opioids for chronic pain is made, the lowest possible effective dosage should be used in order to mitigate risk of dependence and overdose, according to a new CDC guideline.
Experts at NatCon 2016 said symptom severity measurements can fine-tune individual treatment, act as a linkage throughout a patient’s entire treatment plan into recovery, and provide important patient data.